TRIAL DETAIL

Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

Drug:
Trial Name:
Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib
NCT#:
Conditions:
Gastrointestinal Stromal Tumor
Status:
Recruiting
Phase:
3
Start Date 09/12/2020
Age of Trial (yrs) 1.2
Treatment Phase:
Gleevec-resistant
Drug Category:
KIT/PDGFRA inhibitor + VEGF inhibitor
Strategy:
Block KIT/PDGFRA
Trial Type:
Specifically GIST and only GIST
Other Protocol IDs:
SHR-1020-â…¢-303
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Patient Contact:
Quanren Wang, MD (+86) 021-50118402 wangquanren@hrglobe.cn
Contact email:
Contact Phone:
Randomized:
Randomized
IV or Oral:
Oral
Trial Notes:
A Phase III, Open Label, Randomised,Controlled, Multi-centre Study to Assess the Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
Beijing
100036
China